Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions

This publication has 20 references indexed in Scilit:

• Are Patients With Renal Failure Good Candidates for Percutaneous Coronary Revascularization in the New Device Era?
  Circulation, 2000
• Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the cooperative cardiovascular project
  Published by Elsevier ,2000
• Clinical Outcomes of Therapeutic Agents That Block the Platelet Glycoprotein IIb/IIIa Integrin in Ischemic Heart Disease
  Circulation, 1998
• Poor Long-Term Survival after Acute Myocardial Infarction among Patients on Long-Term Dialysis
  New England Journal of Medicine, 1998
• Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
  New England Journal of Medicine, 1997
• Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study
  The Lancet, 1997
• Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
  New England Journal of Medicine, 1994
• Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.
  Circulation, 1990
• Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).
  Circulation, 1988
• Prediction of Creatinine Clearance from Serum Creatinine
  Nephron, 1976